Research article · 31 May 2012
Conference abstractPublished 5 Dec 2016
Ligand conformational analysis enabling improved Nrf2 activators
C4X Discovery Ltd, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In particular, effective anti-inflammatory therapy is required in addition to bronchodilator therapy as disease severity progresses. While oral PDE4 inhibitors are currently used for this purpose and have been shown to be effective on exacerbation rates, their degree of efficacy is disappointing. In this regard, Nrf-2 activators have the potential to be efficacious on exacerbation rate with much a better tolerability profile. However, it has been difficult to create highly potent drug-like non-covalent inhibitors for the key Nrf2/Keap-1 protein-protein interaction (PPI). Nrf2 is a master regulator of the cellâÂ?Â?s antioxidant response and its activation leads to a coordinated antioxidant and anti-inflammatory response. Here we present a detailed 3D-structural analysis of a publicly available Nrf2 activator, which functions by blocking the interaction of Nrf2 with its repressor Keap-1. The variety of conformations that the free activator adopts in solution was precisely measured using the NMR methodology of Blundell et al and this data was combined with results from protein X-ray co-crystallography and in-silico docking. The synergistic combination of these techniques provides unique insights into the disruption of this proteinprotein interface, and demonstrates the power of combining ligand-based and structure-based drug design approaches. These data provide clear, immediate and rational strategies for both conventional and conformational design of the ligand to achieve improved potency.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2 Nov 2015
Design of Novel, Selective and Bioavailable Ligands for Closely Related Receptors and Pharmacophores: Conformational and Topographical Considerations
Conference abstract · 18 Aug 2016
Silacyclohexanes and silaheterocyclohexanes: Synthesis, stereochemistry and conformational analysis
Research article · 30 Sep 2014
CONFORMATIONAL ANALYSIS OF THETHREO AND ERYTHRO DIASTEREOMERIC FORMS OF A GUAIACYL ?-O-4 DIMER USING MOLECULAR MECHANICS CALCULATIONS
Conference abstract · 29 Oct 2012
Screen 3D: A ligand-based 3D similarity search without conformational sampling
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Thorsten Nowak”
- BylineArticles whose byline prints “Sadia Mohammed”
- BylineArticles whose byline prints “Martin Watson”
- BylineArticles whose byline prints “Emma Blaney”
- BylineArticles whose byline prints “Charles Blundell”
- BylineArticles whose byline prints “Craig Fox”

